In December 2024, Checkpoint announced that the U.S. Food and Drug Administration (“FDA”) approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell ...

Frontrunner Josi Shelley said her team of 12 sailed along the Yukon River, but the extreme temperatures were wearing on her.

Located 52 miles into the trail Nenana served as the first checkpoint of the 2025 Iditarod. It marks the third time the race passed through the historic mushing town, with previous stops in 2015 and ...

Shares of Checkpoint Therapeutics rose 4.6% to $3.84 in post-market trading after the Food and Drug Administration approved Unloxcyt (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma, ...

NIKOLAI — Front-runners in the 2024 Iditarod Trail Sled Dog Race pulled into the checkpoint here Tuesday morning saying bare ground had torn up the plastic covering their sled runners and slowed their ...

Broadcaster Anita Rani and her father Bal have become the first team to reach the first checkpoint on Celebrity Race Across The World, leading by more than 23 hours. The third series of the BBC ...

WALTHAM, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results for the first ...

About UNLOXCYT™ (cosibelimab-ipdl)UNLOXCYT is a human immunoglobulin G1 monoclonal antibody that binds PD-L1 and blocks the interaction between PD-L1 and its T cell receptors, PD-1 and B7.1. This ...